心复康丸对冠心病患者超敏CRP影响的研究

目的]探讨心复康丸对冠心病患者的治疗作用及对超敏C反应蛋白(hs-CRP)的影响。方法]将60例冠心病患者随机分为治疗组和对照组,两组均以西医常规处理,治疗组加用心复康丸,观察两组临床疗效及治疗前后hs-CRP的变化。结果]治疗组在临床证候积分、心电图改善有效率均明显优于对照组(P0.05)。结论]心复康丸可改善冠心病患者临床症状,明显降低超敏hs-CRP,心电图好转,提示心复康丸可明显减低冠心病患者炎性指标,降低冠心病危险因素系数,从而改善冠心病患者临床及预后。

Study on the effects of Xinfukang pills on high sensitive CRP in patients with coronary heart disease

Objective] To investigate the therapeutic effect of and the influence of Xinfukang pills on high sensitivity CRP in patients with coronary heart disease. Methods] The 60 cases of coronary heart disease patients were randomly divided into treatment group and control group. The treatment group was treated with Western medicine and Xinfukang pill, the control group only with Western medicine. We observed the clinical curative effect and changes of C-reactive protein (CRP) before and after the two groups before and after treatment. Results] The effective rate of the treatment group was significantly better than that of the control group (P<0.05). Conclusion] Xinfukang pills can improve the clinical symptoms and ECG characteristic for the patients with coronary heart disease (CHD), significantly reduce the high-sensitivity C-reactive protein (hs CRP). It prompts that Xinfukang pills can significantly reduce coronary heart disease patients with inflammatory indicators and the coefficient of risk factors of coronary heart disease, so as to improve the clinical and prognosis in patients with coronary heart disease.